EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+10.28%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.07B
AUM Growth
+$5.07B
(-0.23%)
Cap. Flow
-$254M
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
160
New
22
Increased
53
Reduced
26
Closed
17
Top Buys
| 1 |
Flywire
FLYW
|
$54.4M |
| 2 |
Evolent Health
EVH
|
$47.3M |
| 3 |
dLocal
DLO
|
$32M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$31.2M |
| 5 |
DoubleVerify
DV
|
$30.1M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$180M |
| 2 |
Cintas
CTAS
|
$108M |
| 3 |
Biohaven
BHVN
|
$74.9M |
| 4 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
$68M |
| 5 |
MongoDB
MDB
|
$57.4M |
Sector Composition
| 1 | Healthcare | 43.02% |
| 2 | Technology | 24.93% |
| 3 | Industrials | 12.87% |
| 4 | Consumer Discretionary | 5.44% |
| 5 | Utilities | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Repligen
RGEN
$6.88B
| $20.1M | 0.4% | 119,000 | – | – |
|
77
Intuitive Surgical
ISRG
$170B
| $19.9M | 0.39% | 75,000 | – | – |
|
|
BPMC
78
DELISTED
Blueprint Medicines
BPMC
| $19.2M | 0.38% | 438,500 | – | – |
|
79
KLA
KLAC
$115B
| $19.1M | 0.38% | 50,562 -3,271 | -6% | -$1.23M |
|
80
Annexon
ANNX
$226M
| $18.7M | 0.37% | 3,626,508 | – | – |
|
81
Element Solutions
ESI
$6.21B
| $17.7M | 0.35% | 971,000 | – | – |
|
82
Apellis Pharmaceuticals
APLS
$3.48B
| $17.5M | 0.35% | 339,355 | – | – |
|
|
AESC
83
DELISTED
The AES Corporation
AESC
| $17.5M | 0.34% | 171,200 | – | – |
|
84
Veracyte
VCYT
$2.39B
| $17.4M | 0.34% | 732,000 | – | – |
|
85
Arthur J. Gallagher & Co
AJG
$77.6B
| $17.4M | 0.34% | 92,082 +58,150 | +171% | +$11M |
|
86
Novanta
NOVT
$4.19B
| $17.1M | 0.34% | 125,900 | – | – |
|
87
908 Devices
MASS
$226M
| $17M | 0.34% | 2,230,665 +514,864 | +30% | +$3.92M |
|
88
WEC Energy
WEC
$34.3B
| $16.9M | 0.33% | 180,192 -23,208 | -11% | -$2.18M |
|
89
Ultragenyx Pharmaceutical
RARE
$2.89B
| $16.6M | 0.33% | 359,000 +53,200 | +17% | +$2.46M |
|
|
FRC
90
DELISTED
First Republic Bank
FRC
| $16.1M | 0.32% | 132,371 +356 | +0.3% | +$43.4K |
|
91
Neurocrine Biosciences
NBIX
$13.8B
| $16.1M | 0.32% | 135,000 -100,000 | -43% | -$11.9M |
|
92
IDEX
IEX
$12.4B
| $15.8M | 0.31% | 69,157 +10,757 | +18% | +$2.46M |
|
93
Pentair
PNR
$17.6B
| $15.8M | 0.31% | 350,400 | – | – |
|
94
Insmed
INSM
$28.8B
| $14M | 0.28% | +698,413 | New | +$14M |
|
95
Bruker
BRKR
$5.16B
| $13.8M | 0.27% | +202,006 | New | +$13.8M |
|
96
Sysco
SYY
$38.5B
| $13.5M | 0.27% | 177,100 | – | – |
|
97
Roivant Sciences
ROIV
$8.15B
| $13.5M | 0.27% | 1,690,300 | – | – |
|
98
Sherwin-Williams
SHW
$91.2B
| $12.7M | 0.25% | 53,447 +34,755 | +186% | +$8.25M |
|
|
MRNS
99
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.5M | 0.25% | +3,150,000 | New | +$12.5M |
|
100
CMS Energy
CMS
$21.4B
| $12.4M | 0.24% | 195,500 -46,658 | -19% | -$2.95M |
|